Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bone Marrow Diseases
×
ruxolitinib
×
Clear all
Filters
3
NCT02038036
2021-07-20
RESPONSE-2
Novartis
Phase 3
Completed
149 enrolled
19 charts